clinical trial · NCT04650269
Implementation of Onsite, Rapid ART Initiation Among People Who Inject Drugs Living With HIV at Syringe Services Program
University of Miami·phase4·completed·n = 27
Harm ReductionHIV InfectionsDrug UseBiktarvy 50Mg-200Mg-25Mg TabletHIV care
brief summary
The purpose of this study is to see if providing HIV medicine right away at the IDEA Syringe Services Program will help the participant start and remain in HIV care, including having no detectable HIV in the participant's blood.
started
Mar 4, 2021
primary completion
Dec 31, 2023
completion
Dec 31, 2023
last updated
Jan 8, 2025
official title
Implementation of Onsite, Rapid Antiretroviral Therapy (ART) Initiation Among People Who Inject Drugs Living With HIV at Syringe Services Program
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol